Genetic Variants in Histone Modification Regions Predict Clinical Outcomes of Pemetrexed Chemotherapy in Lung Adenocarcinoma

Yong Hoon Lee, Sook Kyung Do, Shin Yup Lee, Hyo Gyoung Kang, Jin Eun Choi, Mi Jeong Hong, Jang Hyuck Lee, Sunwoong Lee, Won Kee Lee, Ji Yun Jeong, Kyung Min Shin, Ji Eun Park, Sun Ha Choi, Hyewon Seo, Seung Soo Yoo, Jaehee Lee, Seung Ick Cha, Chang Ho Kim, Jae Yong Park

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: This study was conducted to investigate the association between genetic variants in histone modification regions and clinical outcomes of PEM chemotherapy in patients with lung adenocarcinoma. Methods: Potentially functional SNPs were selected using integrated analysis of ChIP-seq and RNA-seq. The associations of 279 SNPs with chemotherapy response and overall survival (OS) were analyzed in 314 lung adenocarcinoma patients who underwent PEM chemotherapy. Results: Among the SNPs investigated, 18 were significantly associated with response to chemotherapy, while 28 with OS. Of these SNPs, rs549794A>G in an enhancer which is expected to regulate the expression of ribosomal protein S3 (RPS3) gene was significantly associated with both worse response to chemotherapy and worse OS (adjusted odds ratio = 0.59, 95% CI = 0.36-0.97, p = 0.04; adjusted hazard ratio = 1.44, 95% CI = 1.09-1.91, p = 0.01, respectively). Previous studies suggested that RPS3, a multi-functional protein with various extraribosomal activities, may play a role in chemotherapy resistance. Therefore, it is postulated that rs549794-induced change in the expression level of RPS3 may affect the response to PEM chemotherapy and consequently the survival outcomes in lung adenocarcinoma patients. Conclusion: This study suggests that genetic variants in the histone modification regions may be useful for the prediction of clinical outcomes of PEM chemotherapy in advanced lung adenocarcinoma.

Original languageEnglish
Pages (from-to)96-104
Number of pages9
JournalOncology
Volume101
Issue number2
DOIs
StatePublished - 1 Feb 2023

Keywords

  • Chemotherapy response
  • Genetic variant
  • Histone modification region
  • Lung adenocarcinoma
  • Survival

Fingerprint

Dive into the research topics of 'Genetic Variants in Histone Modification Regions Predict Clinical Outcomes of Pemetrexed Chemotherapy in Lung Adenocarcinoma'. Together they form a unique fingerprint.

Cite this